Claudia Winkleman Reveals why She’s "obsessed" with CBD > 미얀마한인회

British television and radio presenter Claudia Winkleman is the latest celebrity to endorse the benefits of CBD. Strictly Come Dancing host Claudia Winkleman has been announced as a brand ambassador for UK company Cannaray CBD. The partnership is said to reflect Winkleman’s own personal interest in CBD, her support for the brand, and belief that Balance Bloom CBD Gummies products can have positive impact on everyday life. Evidence-led education for clinicians, industry and patient advocates. Winkleman has been using the products for over six months prior to the partnership after they were recommended to help improve her sleep and cope with work and life pressures. The announcement marks the launch of Cannaray’s "Join the CBD Revolution" national outdoor and digital advertising campaign. Winkleman uses Cannaray CBD products to help her unwind and improve sleep, and is encouraging others to join the "CBD revolution". She said: "I’ve always wanted to lead a revolution and I’m delighted to be partnering with Cannaray BalanceBloom CBD Gummies to lead the UK’s CBD revolution.

I’ve become obsessed with CBD this year as it really helps me sleep and stay calm during bonkers days. Cannaray’s CEO Scott Maguire said: "At Cannaray, we want to make it as easy as possible for people to experience the many benefits of CBD, and we are hugely excited to be leading the CBD revolution in partnership with Claudia. She is one of the UK’s most trusted people, a passionate advocate for CBD and an ideal partner to encourage millions of people to try CBD for the first time. "We know that consumers and retailers are all looking for a trusted brand leader within CBD. Cannaray CBD says it aims to help people benefit from CBD with its range of products, all of which are triple lab tested to guarantee purity, including CBD oil drops for day and night, capsules, gummies and muscle balm. A round-up of the latest science, regulation and developments across the UK and Europe - in your inbox every week. Stephanie is the editor of Cannabis Wealth and Psychedelic Health, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. After working for a number of years as a local journalist, Stephanie became the editor of two publications covering health and wellness, including psychedelics and global developments in cannabis, before joining the team at Aspect publishing. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and Balance Bloom CBD Gummies through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

After clearing its way through EU-GMP certification, a North Macedonian company is now able to export medical cannabis products to the EU. How will this affect the landscape of medical cannabis in Europe? In Macedonia, cannabis is not legal for recreational use at all, and there are no decriminalization or personal use laws to boot. However, in 2016, Macedonia did approve a bill for medical cannabis within the country. As per Macedonian laws, which sync with EU laws here, oils and extracts can have up to .2% THC and still be sold without a prescription. Cannabis with any higher THC amount can be obtained through prescription. The laws allow for private citizens to make use of medical cannabis, as well as for Macedonia to enter into the legal medical cannabis market with laws to cover cultivation, production, and exportation for medicinal use. Since that time, and according to internal legislation, Macedonia has been exporting extracts, oils, and tinctures, but that’s it.

And while that does account for about 30% of the market, the great majority - 70% - relies on smokable hemp flowers, which Macedonia had not been cleared to export at all. Until now though, the EU was not included in exportable locations for any goods as no companies had EU-GMP authorization. What’s the biggest problem? One of the biggest issues for Macedonia is that cannabis flowers have not been legalized for exportation. A big factor in this inability comes from internal licensing issues that stem from allegations of corruption. The allegations centered around former Prime Minister Zoran Zaev showing preferential treatment when giving out licenses, opting to give them to friends and family members which would, in turn, benefit him personally. There were also a lot of questions and calls for specifications relating to how licensing would generally work, issues related to the program being government run, and opposition to the €500 bank guarantee that many thought would make it harder for smaller enterprises to gain ground.

With Zaev no longer in office, and with Corona issues subsiding enough to get back to regular business, the issue of Macedonia selling flowers can once again be broached. But in the meantime, while flowers might still be illegal for export, and while several companies have been awarded licensing for cultivation, only one company thus far has received EU GMP clearance to export its products (by Macedonian law) into the EU, making Macedonia a new competitor in the medicinal marijuana game there. So, who is it? The company PharmaCann Polska received the EU-GMP certification to produce cannabis extracts (still not flowers) in its North Macedonia production facility. PharmaCann is actually based out of Warsaw, Poland, and received its EU-GMP certifications in March (amid Corona), by the Chief Pharmaceutical Inspectorate of Poland, after full inspections of the facility were made. The facility is reportedly an indoor growing operation that can both cultivate and manufacture products. Zlatko Keskovski, PharmaCann’s CEO stated: "When I hear about the prices of medical cannabis extracts in Germany and other European countries, I can’t believe how expensive they are.